CFO AND TREASURERCIK 0001636178
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Edgemond JamesCFO AND TREASURER |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $397K 687 sh | Apr 21, 2026 traded Apr 20, 2026 | |
Edgemond JamesCFO AND TREASURER |
| UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan |
| SELL |
| $289K 500 sh |
| Apr 21, 2026 traded Apr 20, 2026 |
| 1 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $197K 340 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $284K 488 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $573K 983 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $589K 1,009 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $282K 482 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 1 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $139K 238 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 0 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Option exercise · 10b5-1 plan | M | — 10.0K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Option exercise · 10b5-1 plan | M | $1.35M 10.0K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $504K 880 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $806K 1,398 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $885K 1,543 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $254K 442 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $581K 1,010 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Option exercise · 10b5-1 plan | M | $1.35M 10.0K sh | Apr 14, 2026 traded Apr 13, 2026 |
| 1 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $160K 281 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $838K 1,457 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $780K 1,354 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 0 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $23K 40 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 0 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Option exercise · 10b5-1 plan | M | — 10.0K sh | Apr 14, 2026 traded Apr 13, 2026 |
| 0 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $23K 40 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 11 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $1.07M 1,860 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $347K 601 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 1 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $232K 400 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $693K 1,210 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $925K 1,603 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $660K 1,154 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 18 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $1.13M 1,956 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 15 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $915K 1,586 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 15 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $934K 1,617 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 11 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $659K 1,139 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 15 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $710K 1,224 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 18 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $1.02M 1,756 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $94K 162 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 20 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Option exercise · 10b5-1 plan | M | $1.35M 10.0K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 3 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Option exercise · 10b5-1 plan | M | — 10.0K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 11 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $322K 560 sh | Apr 10, 2026 traded Apr 9, 2026 |